Action MorphoSys - MOR

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Premium

Dernier

18,96

Prix Achat

18,60

Prix Vente

19,00

Volume échangé

0,00 Fourchette du Jour 0,00

0,00 Plage de 52 semaines 0,00

Clôture Veille

18,96

Ouverture

Dernière Transaction

Dernière heure de transaction

Volume moyen (3 m)

Volume financier

VWAP

MorphoSys Announces Voluntary Delisting from the Nasdaq Global Market

MorphoSys AG (FSE: MOR; NASDAQ: MOR) today announced that it has formally notified the Nasdaq Stock Market of its intention to voluntarily delist...

Kuehn Law Encourages DM, SHCR, MOR, and ALE Investors to Contact Law Firm

Kuehn Law Encourages DM, SHCR, MOR, and ALE Investors to Contact Law Firm PR Newswire NEW YORK, July 8, 2024...

MorphoSys and Novartis Sign Delisting Agreement and Intend to Implement a Merger Squeeze-out of MorphoSys’ Minority Shareholders

MorphoSys AG (FSE: MOR; NASDAQ: MOR) today announced that the company has entered into a delisting agreement with Novartis BidCo AG and Novartis...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form SC 14D9/A - Solicitation, recommendation statements: [Amend]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	DR
4	0	0	0	0	0	0	0	DR
12	0	0	0	0	0	0	0	DR
26	0	0	0	0	0	0	0	DR
52	0	0	0	0	0	0	0	DR
156	0	0	0	0	0	0	0	DR
260	0	0	0	0	0	0	0	DR

MOR - Frequently Asked Questions (FAQ)

What is the current MorphoSys share price?

The current share price of MorphoSys is US$ 18,96

What is the 1 year trading range for MorphoSys share price?

MorphoSys has traded in the range of US$ 0,00 to US$ 0,00 during the past year

Volume
% Gagnants
% Perdants

Symbole	Prix	Vol.
UPXIUpexi Inc	US$ 9,83 (328,32%)	100,38M
SHFSSHF Holdings Inc	US$ 4,17 (87,00%)	43,5M
MLGOMicroAlgo Inc	US$ 11,84 (74,63%)	78,43M
MKDWMKDWELL Tech Inc	US$ 0,4027 (73,35%)	40,8M
MTENMingteng International Corporation Inc	US$ 6,24 (47,87%)	317,66k
AIEVThunder Power Holdings Inc	US$ 0,049999 (-63,02%)	6,25M
LXEHLixiang Education Holding Company Ltd	US$ 2,88 (-57,89%)	1,57M
AREBAmerican Rebel Holdings Inc	US$ 2,38 (-53,88%)	11,97M
SXTCChina SXT Pharmaceuticals Inc	US$ 1,029 (-52,36%)	1,66M
RTCBaijiayun Group Ltd	US$ 0,1862 (-49,68%)	7,75M
DMNDamon Inc	US$ 0,0041 (20,59%)	621,47M
NVDANVIDIA Corporation	US$ 96,91 (-4,51%)	288,68M
STSSSharps Technology Inc	US$ 0,0319 (-0,31%)	162,99M
RSLSReShape Lifesciences Inc	US$ 0,383 (23,67%)	152,04M
TSLLDirexion Daily TSLA Bull 2X Trust ETF	US$ 6,7742 (-11,68%)	151,31M

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

MorphoSys AG (MOR)

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Statistiques et détails clés

MOR Dernières nouvelles

MorphoSys Announces Voluntary Delisting from the Nasdaq Global Market

Kuehn Law Encourages DM, SHCR, MOR, and ALE Investors to Contact Law Firm

MorphoSys and Novartis Sign Delisting Agreement and Intend to Implement a Merger Squeeze-out of MorphoSys’ Minority Shareholders

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form SC 14D9/A - Solicitation, recommendation statements: [Amend]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

MorphoSys Announces Voluntary Delisting from the Nasdaq Global Market

Kuehn Law Encourages DM, SHCR, MOR, and ALE Investors to Contact Law Firm

MorphoSys and Novartis Sign Delisting Agreement and Intend to Implement a Merger Squeeze-out of MorphoSys’ Minority Shareholders

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form SC 14D9/A - Solicitation, recommendation statements: [Amend]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

MOR - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	DR
4	0	0	0	0	0	0	0	DR
12	0	0	0	0	0	0	0	DR
26	0	0	0	0	0	0	0	DR
52	0	0	0	0	0	0	0	DR
156	0	0	0	0	0	0	0	DR
260	0	0	0	0	0	0	0	DR

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	DR
4	0	0	0	0	0	0	0	DR
12	0	0	0	0	0	0	0	DR
26	0	0	0	0	0	0	0	DR
52	0	0	0	0	0	0	0	DR
156	0	0	0	0	0	0	0	DR
260	0	0	0	0	0	0	0	DR

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

MorphoSys AG (MOR) Cours

MorphoSys AG (MOR)

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Statistiques et détails clés

MOR Dernières nouvelles

MorphoSys Announces Voluntary Delisting from the Nasdaq Global Market

Kuehn Law Encourages DM, SHCR, MOR, and ALE Investors to Contact Law Firm

MorphoSys and Novartis Sign Delisting Agreement and Intend to Implement a Merger Squeeze-out of MorphoSys’ Minority Shareholders

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form SC 14D9/A - Solicitation, recommendation statements: [Amend]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

MorphoSys Announces Voluntary Delisting from the Nasdaq Global Market

Kuehn Law Encourages DM, SHCR, MOR, and ALE Investors to Contact Law Firm

MorphoSys and Novartis Sign Delisting Agreement and Intend to Implement a Merger Squeeze-out of MorphoSys’ Minority Shareholders

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form SC 14D9/A - Solicitation, recommendation statements: [Amend]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

MOR - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	DR
4	0	0	0	0	0	0	0	DR
12	0	0	0	0	0	0	0	DR
26	0	0	0	0	0	0	0	DR
52	0	0	0	0	0	0	0	DR
156	0	0	0	0	0	0	0	DR
260	0	0	0	0	0	0	0	DR